FY23 Corporate Strategy and Sustainability Journey slide image

FY23 Corporate Strategy and Sustainability Journey

Our ESG goals Transforming to build a sustainable future Being committed to environmental stewardship Reducing carbon emissions • 100% renewable power by 2030 • Carbon neutrality in our direct operations • (Scope 1 and Scope 2 emissions) by 2030 12.5% reduction in indirect carbon emissions across our supply chain (Scope 3 emissions) by 2030 Water positivity Be water positive by 2025 Making our products accessible and affordable for patients Access • Serve 1.5 billion patients by 2030 Affordability • 25% of our new-launches to be first-to- market by 2027 Contributing to a fairer and more socially inclusive world Equity, diversity and inclusion • At least 35% women in senior leadership (3X from the current baseline) by 2030 • Gender parity by 2035 • 3% of our workforce to be persons with disabilities (PWD) by 2030 • 100% living wages for our on-premise extended workforce by 2025 Compliance, Ethics and Corporate Governance Meet the highest standards on compliance and ethics backed by robust corporate governance Innovation • 3 innovative solutions to improve the standard of treatment every year from 2027 Enhancing trust with our stakeholders . ESG disclosures Progressively enhance disclosure on our ESG progress to reach top quartile by 2025 Strategic suppliers • 100% of our strategic suppliers to be compliant with our chosen ESG framework by 2030
View entire presentation